TAP Rapid Test Tapentadol Drug Abuse Test Kit Detection Of Tapentadol In Urine
Brand Name:Citest
Certification:CE
Model Number:DTAP-114
Minimum Order Quantity:N/A
Place of Origin:-
Price:negotiation
Contact Now
Add to Cart
Verified Supplier
Location:
Hangzhou Zhejiang
Address:
170-422, Richards Street, Vancouver BC V6B 2Z4, CANADA
Supplier`s last login times:
within 28 hours
Product Details
Company Profile
Product Details
TAP Rapid Test Panel, Tapentadol abuse, Drugs of Abuse, detection of Tapentadol in Urine
Tapentadol is an opioid pain medication used to treat mod-erate to severe pain. It may be habit-forming, even at regular doses. A rapid test for the qualitative detection of Tapentadol in human urine.
For professional in vitro diagnostic use only
| Product: | TAP Rapid Test Panel, Tapentadol Abuse, Drugs Of Abuse, Detection Of Tapentadol In Urine |
| Cat No.: | DTAP-114 |
| Certificate: | CE |
| Pack: | 40T |
| Shelf Life: | 2 Years |
| Specificity: | 98.20% |
| Cut-Off: | 500 Ng/mL |
| Brand: | Citest |
| Principle: | Chromatographic Immunoassay |
| Specimen: | Urine |
| Reading Time: | 5 Minutes |
| Storage Temperature: | 2-30°C |
| Sensitivity: | 94.40% |
| Accuracy: | 96.70% |
| PRODUCT FEATURES: | Multiple Formats Available |
Application
The TAP Rapid Test Panel (Urine) is a rapid chromatographic
immunoassay for the detection of Tapentadol in human urine at a
cut-off concentration of 1000 ng/mL. This test will detect other
related compounds, please refer to the Analytical Specificity table
in this package insert. This assay provides only a qualitative
preliminary analytical test result. A more specific alternate
chemical method must be used in order to obtain a confirmed
analytical result. Gas chromatography/mass spectrometry (GC/MS) is
the preferred confirmatory method. Clinical consideration and
professional judgment should be applied to any drug of abuse test
result, particularly when preliminary positive results are used.
PRECAUTIONS
• For professional in vitro diagnostic use only. Do not use after
the expiration date.
• The test should remain in the sealed pouch until use.
• All specimens should be considered potentially hazardous and
handled in the same manner as an infectious agent.
• The used test should be discarded according to local regulations.
SPECIMEN COLLECTION AND PREPARATION
Urine Assay
The urine specimen must be collected in a clean and dry container.
Urine collected at any time of the day may be used. Urine specimens
exhibiting visible particles should be centrifuged, filtered or
allowed to settle to obtain clear specimen for testing.
Specimen Storage
Urine specimens may be stored at 2-8 °C for up to 48 hours prior to
testing. For long-term storage, specimens may be frozen and stored
below -20 °C. Frozen specimens should be thawedand mixed before
testing.
DIRECTIONS FOR USE
Allow the test, urine specimen, and/or controls to reach room
temperature (15-30 ºC) prior to testing.
1. Bring the pouch to room temperature before opening it. Remove
the test panel from the sealed pouch and use it within one hour.
2. Remove the cap.
3. With the arrow pointing toward the urine specimen, immerse the
test panel vertically in the urine specimen for at least 10 to 15
seconds. Immerse the strip to at least the level of the wavy lines,
but do not touch the plastic device.
4. Replace the cap and place the test panel on a non-absorbent flat
surface.
5. Start the timer and wait for the colored line(s) to appear.
6. Read results at 5 minutes. Do not interpret the result after 10
minutes.
INTERPRETATION OF RESULTS
NEGATIVE:* Two colored lines appear. One colored line should be in the
control line region (C), and another colored line should be in the
test line region (T). A negative result indicates that the
Tapentadol concentration is below the detectable level (1000
ng/mL).
*NOTE: The shade of color in the test line region (T) may vary, but it
should be considered negative whenever there is even a faint
colored line.
POSITIVE: One colored line appears in the control line region (C). No line
appears in the test line region (T). A positive result indicates
that the Tapentadol concentration exceeds the detectable level
(1000 ng/mL).
INVALID: Control line fails to appear. Insufficient specimen volume or
incorrect procedural techniques are the most likely reasons for
control line failure. Review the procedure and repeat the test
using a new test. If the problem persists, discontinue using the
test kit immediately and contact local distributor.
SUMMARY
Tapentadol is used to help relieve moderate to severe short-term
pain such as pain from an injury or after surgery. It belongs to a
class of drugs known as opioid analgesics. It works in the brain to
change how the body feels and responds to pain.1 Tapentadol is
mainly metabolized in the liver and is excreted by the kidneys in
urine as well as in feces. The major pathway of metabolism is
conjugation with glucuronic acid to produce glucuronides;
tapentadol-O-glucuronide is the major metabolite.2 For monitoring
the intake regularly, Tapentadol is tested in human urine. The TAP
Rapid Test Panel (Urine) is a rapid urine screening test that can
be performed without the use of an instrument. The test utilizes a
monoclonal antibody to selectively detect elevated levels of
Tapentadol in urine. The TAP Rapid Test Panel (Urine) yields a
positive result when
Tapentadol in urine exceed 1000 ng/mL.
TAP Rapid Test Tapentadol Drug Abuse Test Kit Detection Of Tapentadol In Urine
Inquiry Cart
0